Isoleucilactucin Ameliorates Coal Fly Ash-Induced Inflammation Through
Total Page:16
File Type:pdf, Size:1020Kb
International Journal of Molecular Sciences Article Isoleucilactucin Ameliorates Coal Fly Ash-Induced Inflammation through the NF-κB and MAPK Pathways in MH-S Cells H. M. Arif Ullah 1 , Tae-Hyung Kwon 2,*, SeonJu Park 3 , Sung Dae Kim 1 and Man Hee Rhee 1,* 1 Department of Veterinary Medicine, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea; [email protected] (H.M.A.U.); [email protected] (S.D.K.) 2 Department of Research and Development, Chuncheon Bio-Industry Foundation (CBF), Chuncheon 24232, Korea 3 Chuncheon Center, Korea Basic Science Institute (KBSI), Chuncheon 24341, Korea; [email protected] * Correspondence: [email protected] (T.-H.K.); [email protected] (M.H.R.); Tel.: +82-33-258-6993 (T.-H.K.); +82-53-950-5967 (M.H.R.) Abstract: We investigated whether isoleucilactucin, an active constituent of Ixeridium dentatum, reduces inflammation caused by coal fly ash (CFA) in alveolar macrophages (MH-S). The anti- inflammatory effects of isoleucilactucin were assessed by measuring the concentration of nitric oxide (NO) and the expression of pro-inflammatory mediators in MH-S cells exposed to CFA-induced inflammation. We found that isoleucilactucin reduced CFA-induced NO generation dose-dependently in MH-S cells. Moreover, isoleucilactucin suppressed CFA-activated proinflammatory mediators, including cyclooxygenase-2 (COX2) and inducible NO synthase (iNOS), and the proinflammatory cytokines such as interleukin-(IL)-1β, IL-6, and tumor necrosis factor (TNF-α). The inhibiting Citation: Ullah, H.M.A.; Kwon, properties of isoleucilactucin on the nuclear translocation of phosphorylated nuclear factor-kappa B T.-H.; Park, S.; Kim, S.D.; Rhee, M.H. (p-NF-κB) were observed. The effects of isoleucilactucin on the NF-κB and mitogen-activated protein Isoleucilactucin Ameliorates Coal Fly kinase (MAPK) pathways were also measured in CFA-stimulated MH-S cells. These results indicate Ash-Induced Inflammation through that isoleucilactucin suppressed CFA-stimulated inflammation in MH-S cells by inhibiting the NF-κB the NF-κB and MAPK Pathways in and MAPK pathways, which suggest it might exert anti-inflammatory properties in the lung. MH-S Cells. Int. J. Mol. Sci. 2021, 22, 9506. https://doi.org/10.3390/ Keywords: lung macrophages; isoleucilactucin; anti-inflammatory properties; NF-κB pathway; ijms22179506 AMPK pathway Academic Editor: Stefania Marzocco Received: 13 August 2021 1. Introduction Accepted: 29 August 2021 Published: 1 September 2021 Inflammation is a critical aspect of the immune response against cell damage and pathogens, which also provides a defense mechanism to remove harmful stimuli [1–3]. Publisher’s Note: MDPI stays neutral Increased movement of plasma and leukocytes from the blood into wounded regions with regard to jurisdictional claims in causes acute inflammation, which is an initial response of the organism to damaging published maps and institutional affil- stimuli. When it becomes chronic, inflammation causes a gradual shift in the cell types iations. present at the site of inflammation and can result in a destruction or regeneration of tissues, depending on the context [4]. Dysregulated inflammation is associated with various chronic diseases [2,5]. Macrophages play a crucial role in inflammatory processes, primarily by producing proinflammatory mediators that include nitric oxide (NO), inducible NO Copyright: © 2021 by the authors. synthase (iNOS), cyclooxygenase-2 (COX-2), as well as the cytokines interleukin (IL)-1β, Licensee MDPI, Basel, Switzerland. IL-6, and tumor necrosis factor-α (TNF-α)[6,7]. Therefore, inhibiting proinflammatory This article is an open access article macrophage transformation is considered a critical strategy in the treatment of numerous distributed under the terms and inflammatory disorders. conditions of the Creative Commons In the last few decades, environmental contaminants were shown to cause immuno- Attribution (CC BY) license (https:// logic dysfunction in chronic respiratory inflammatory disorders: asthma, chronic respira- creativecommons.org/licenses/by/ tory diseases, chronic obstructive pulmonary disease (COPD), and various types of lung 4.0/). Int. J. Mol. Sci. 2021, 22, 9506. https://doi.org/10.3390/ijms22179506 https://www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 2 of 13 In the last few decades, environmental contaminants were shown to cause immuno- logic dysfunction in chronic respiratory inflammatory disorders: asthma, chronic respira- Int. J. Mol. Sci. 2021, 22, 9506 2 of 12 tory diseases, chronic obstructive pulmonary disease (COPD), and various types of lung cancer [1,6,8–10]. COPD is the world’s third leading cause of death, with 3 million indi- viduals dying from the disease in 2016 [11]. In modern industrial countries, particulate mattercancer (PM) [1,6,8 represents–10]. COPD the is most the world’s dangerous third ai leadingr contaminant cause of [12]. death, The with main 3 millionsources individ- of PM includeuals dying outdoor from pollutants the disease from in 2016 gasoline [11]. In fuel modern burning industrial in automobiles countries, and particulate industries, matter as well(PM) as represents indoor pollutants the most from dangerous cigarette air smok contaminante and culinary [12]. The exhausts main sources [6,13]. ofAccording PM include to previousoutdoor research, pollutants exposure from gasoline to PM has fuel been burning linked in automobilesto worseningand of asthma industries, symptoms, as well as as wellindoor as increased pollutants hospitalization from cigarette smoke and mortality and culinary in individuals exhausts [6 with,13]. AccordingCOPD [14,15]. to previous Expo- sureresearch, to PM exposure could induce to PM alveolar has been macropha linked toges worsening to produce of asthmaexcessive symptoms, amounts asof wellproin- as flammatoryincreased hospitalization mediators, such and as mortalityiNOS, COX2, in individuals TNF-α, IL-1 withβ, and COPD IL-6, [14which,15]. determine Exposure toa widePM couldrange induceof pathological alveolar macrophagesand clinical symptoms to produce [9,16]. excessive amounts of proinflammatory α β mediators,The pharmaceutical such as iNOS, industry’s COX2, TNF- interest, IL-1 in, natural and IL-6, drugs which has determine grown, thus a wide including range of naturalpathological resources and clinicalin drug symptomsdevelopment [9,16 [3,17,]. 18]; indeed, over 100 medications derived The pharmaceutical industry’s interest in natural drugs has grown, thus including from natural products are now being tested in clinical trials [3,19]. Isoleucilactucin, one of natural resources in drug development [3,17,18]; indeed, over 100 medications derived the major active constituents of Ixeridium dentatum, has been reported to have amylase from natural products are now being tested in clinical trials [3,19]. Isoleucilactucin, one secretion activity after treatment with high glucose in human salivary gland cells [20]. of the major active constituents of Ixeridium dentatum, has been reported to have amylase Coal fly ash (CFA) is made up of a variety of liquid and solid PM, including asbestos, coal, secretion activity after treatment with high glucose in human salivary gland cells [20]. and combustion particles of various sizes and origins [1,6,21]. However, the effect of iso- Coal fly ash (CFA) is made up of a variety of liquid and solid PM, including asbestos, leucilactucin in the CFA-stimulated inflammatory cascade on alveolar macrophages (MH- coal, and combustion particles of various sizes and origins [1,6,21]. However, the effect S) remains elusive. The goal of this study is to determine whether isoleucilactucin has anti- of isoleucilactucin in the CFA-stimulated inflammatory cascade on alveolar macrophages inflammatory activities upon CFA-induced inflammatory stimulation of MH-S cells. (MH-S) remains elusive. The goal of this study is to determine whether isoleucilactucin has anti-inflammatory activities upon CFA-induced inflammatory stimulation of MH-S cells. 2. Results 2.1.2. ResultsIsoleucilactucin Protected against CFA-Induced Nitric Oxide Production and Cell Death in Alveolar2.1. Isoleucilactucin Macrophage Protected(MH-S) Cells against CFA-Induced Nitric Oxide Production and Cell Death in Alveolar Macrophage (MH-S) Cells Nitric oxide (NO) is a vital regulator in the inflammatory process, while excess NO contributesNitric oxideto the (NO)development is a vital regulatorof numerous in the inflammatory inflammatory disorders process, while[22–24]. excess In our NO study,contributes the NO to levels the development in murine MH-S of numerous cells in inflammatoryresponse to CFA disorders stimulation [22–24 were]. In ourassessed study, usingthe NO the levels Griess in reaction. murine MH-S Isoleucilactucin cells in response decreased to CFA NO stimulation induction werepotently assessed and dose-de- using the pendentlyGriess reaction. (Figure Isoleucilactucin 1A). decreased NO induction potently and dose-dependently (Figure1A). FigureFigure 1. 1. EffectEffect of of isoleucilactucin isoleucilactucin on on coal coal fly fly ash ash (CFA)-induced (CFA)-induced nitric nitric oxide oxide (NO) (NO) generation generation and and viabilityviability in in MH-S MH-S cells. cells. (A (A) )Cells Cells were were categorized categorized into into six six groups: groups: basal basal (control), (control), CFA CFA (2.5 (2.5 μµg/mL),g/mL), andand four four concentrations concentrations of of CFA CFA with with isoleucilactucin isoleucilactucin (12.5, (12.5, 25, 25, 50, 50, and and 100 100 μµM).M).